Successful treatment of recalcitrant pemphigoid gestationis with omalizumab: report of two cases
J Eur Acad Dermatol Venereol
.
2022 Sep;36(9):e720-e722.
doi: 10.1111/jdv.18227.
Epub 2022 May 25.
Authors
M P Konstantinou
1
,
F Jendoubi
1
,
F Fortenfant
2
,
J Milhes
2
,
P Joly
3
,
C Bost
2
Affiliations
1
Dermatology Department, University Hospital of Toulouse, Paul Sabatier University, Toulouse, France.
2
Immunology Department, University Hospital of Toulouse, Paul Sabatier University, Toulouse, France.
3
Dermatology Department, University Hospital of Rouen, Rouen, France.
PMID:
35592910
DOI:
10.1111/jdv.18227
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Female
Humans
Omalizumab / therapeutic use
Pemphigoid Gestationis* / drug therapy
Pemphigoid, Bullous*
Pregnancy
Pregnancy Complications*
Substances
Omalizumab